Oxford BioDynamics Plc (AIM:OBD)
0.2150
-0.0100 (-4.44%)
Dec 31, 2025, 12:34 PM GMT+1
Oxford BioDynamics Market Cap
Oxford BioDynamics has a market cap or net worth of 9.23 million as of December 31, 2025. Its market cap has increased by 210.01% in one year.
Market Cap
9.23M
Enterprise Value
12.94M
Revenue
1.10M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.22
Market Cap Chart
Since December 6, 2016, Oxford BioDynamics's market cap has decreased from 136.90M to 9.23M, a decrease of -93.26%. That is a compound annual growth rate of -25.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 31, 2025 | 9.23M | 92.61% |
| Dec 31, 2024 | 4.79M | -91.54% |
| Dec 29, 2023 | 56.64M | 125.13% |
| Dec 30, 2022 | 25.16M | -34.45% |
| Dec 31, 2021 | 38.38M | -50.04% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 6, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 213.19B |
| GSK plc | 73.15B |
| Haleon | 33.22B |
| Smith & Nephew | 10.43B |
| Convatec Group | 4.74B |
| Hikma Pharmaceuticals | 3.40B |
| Genus | 1.73B |
| HUTCHMED (China) | 1.71B |